GlassScriptPhysician profile
Samuel Nels Andersen
NPI 1942769997
$1,087.39
in general payments reported to CMS, 2019-2025
11 companies · $523 in 2025
The $523 reported for 2025 was more than what 75% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.43 · 2022: $167 · 2023: $122 · 2024: $251 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $238.45 | 2025 | Libtayo |
| Novocure INC. | $199.15 | 2024-2025 | Optune Gio, Optune |
| Incyte Corporation | $124.26 | 2024 | Jakafi |
| Gilead Sciences, INC. | $122.13 | 2023 | Vemlidy |
| La Jolla Pharmaceutical Company | $118.16 | 2022 | |
| Caris Mpi, INC. | $80.00 | 2025 | Mi Cancer Seek |
| Reflexion Medical, INC. | $73.46 | 2022-2024 | Reflexion Medical Radiotherapy System |
| Siemens Medical Solutions USA, INC. | $58.05 | 2025 | |
| Bioprotect Medical, INC. | $26.71 | 2025 | Bioprotect Balloon Implant System |
| Genentech USA, INC. | $24.43 | 2019 | |
| Boston Scientific Corporation | $22.59 | 2025 | Cryoablation Needles |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.